Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
It is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, which may lead to enhanced weight loss and metabolic effects compared to single or dual agonists
Almost all GLP-1 medications currently on the market are available only in an injectable form except for semaglutide, which is also available in an oral formulation (Rybelsus and oral Wegovy)
How do GLP-1 medications like Wegovy and Mounjaro work
A comprehensive safety and tolerability study evaluated approximately 900 participants across six trials with the following protocols: Subcutaneous/Intravenous Protocols: Single doses ranging from 25 to 400 mcg/kg body weight were tested
